UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 4, 2014
XYLEM INC.
(Exact name of registrant as specified in its charter)
| Indiana | 001-35229 | 45-2080495 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 1 International Drive Rye Brook, New York |
10573 | |
| (Address of principal executive offices) | (Zip Code) |
(914) 323-5700
(Registrant’s telephone number, including area code)
1133 Westchester Avenue, White Plains NY 10604
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02 | Results of Operations and Financial Condition |
Attached hereto as Exhibit 99.1 and incorporated herein by reference is the news release issued by Xylem Inc. on February 4, 2014, announcing the financial results for the quarter and fiscal year ended December 31, 2013. This information shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act.
| Item 8.01 | Other Events |
The Company’s Board of Directors declared a dividend in the amount of $0.128 per share for the first quarter of 2014, an increase of 10 percent from the dividend paid in the fourth quarter in 2013. The declared dividend is payable on March 19, 2014 to shareholders of record on February 19, 2014.
| Item 9.01 | Financial Statements and Exhibits |
| (d) | Exhibits. |
| Exhibit No. |
Description | |
| 99.1 | News Release issued by Xylem Inc. on February 4, 2014. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| XYLEM INC. | ||||
| Date: February 4, 2014 | By: | /s/ Michael T. Speetzen | ||
| Michael T. Speetzen | ||||
| Senior Vice President and Chief Financial Officer (Authorized Officer of Registrant) | ||||
EXHIBIT INDEX
| Exhibit No. |
Description | |
| 99.1 | News Release issued by Xylem Inc. on February 4, 2014. | |
Exhibit 99.1
Xylem Inc.
1 International Drive, Rye Brook N.Y. 10573
Tel +1.914.323.5700 Fax +1.914.696.2960
| Contacts: | Media | Investors | ||
| Tom Glover +1 (914) 323-5891 | Phil DeSousa +1 (914) 323-5930 | |||
| tom.glover@xyleminc.com | phil.desousa@xyleminc.com |
Xylem Inc. reports fourth quarter and full year 2013 results reflecting record Q4 revenue and improved operational performance
| • | Fourth quarter 2013 adjusted net income was $103 million or $0.56 per share, up 19 percent over fourth quarter 2012; GAAP net income was $68 million or $0.37 per share |
| • | Full year 2013 adjusted net income was $311 million or $1.67 per share; FY GAAP net income was $228 million or $1.22 per share |
| • | Fourth quarter 2013 revenue was a record $1.03 billion, up 7 percent; FY 2013 revenue was $3.84 billion, up 1 percent |
| • | Fourth quarter 2013 adjusted operating margin up 60 basis points; up 180 basis points as reported |
| • | Fourth quarter organic orders up 5 percent over fourth quarter 2012 |
| • | Company issues full-year 2014 financial guidance, sees FY 2014 adjusted EPS of $1.85 - $2.00 per share for earnings growth of 11 to 20 percent on revenue growth of 2 to 4 percent |
| • | Xylem Board of Directors approves a 10 percent increase in the dividend for first quarter 2014 |
RYE BROOK, N.Y., February 4, 2014 – Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported fourth quarter 2013 net income of $68 million, or $0.37 per share. Excluding the impact of restructuring, realignment and other special items, adjusted net income was $103 million or $0.56 per share, up 9 cents or 19 percent from the comparable period in 2012. Fourth quarter revenue was $1.03 billion, up 7 percent, reflective of strength in industrial and public utility markets. Fourth quarter adjusted operating margins improved 60 basis points, driven by higher volume and the impact of efficiency and cost control measures undertaken throughout the year.
“We are very pleased to deliver another strong quarter with upturns in revenue and earnings while continuing to execute our aggressive growth and operational improvement initiatives,” said Steve Loranger, chief executive officer and president of Xylem. “Organic order and revenue growth during the quarter point to the early success of our sales force accountability initiative and the strength of our business portfolio as economic conditions continue to improve. We launched new products such as our e-HMTM energy efficient stainless steel industrial pump, and won new projects, such as a large contract to supply the technology and equipment for a sophisticated drainage system on the New Jersey coastline following the damage caused by Super Storm Sandy. Under the leadership of our new regional and growth center leaders, all of our businesses substantially contributed to fourth quarter performance and are energized to build even more momentum as we begin 2014.”
Loranger said the company continues to execute cost reduction actions including further refinement of the global organization and footprint, and has reinvigorated its productivity initiatives around global sourcing and Lean Six Sigma.
“We intend to bring more to the bottom line by continuing to take out costs where we can, and continue deploying our capital to invest in the business, and maximize shareholder return,” Loranger said.
Xylem today also announced that its Board of Directors declared a dividend in the amount of $0.128 per share for the first quarter of 2014, an increase of 10 percent, payable on March 19, 2014 to shareholders of record as of February 19, 2014.
For the full year 2013, Xylem revenues were $3.84 billion, up 1 percent over 2012. Full year reported net income was $228 million, or $1.22 per share with an operating margin of 9.5 percent. Adjusted net income, excluding the impact of restructuring, realignment and other special items, was $311 million or $1.67 per share. Full year 2013 adjusted operating margins were 11.8 percent. Free cash flow was $198 million, 87 percent of net earnings.
Full-year 2014 Outlook
Xylem forecasts full year 2014 revenue of approximately $4 billion, up 2 to 4 percent over 2013. Full year 2014 adjusted net income is expected to be in the range of $345 to $370 million, for adjusted earnings per share of $1.85 to $2.00, reflecting 11 to 20 percent growth over 2013. The company anticipates that restructuring and realignment costs will range from $40 to $50 million for the year.
“We’re encouraged by signs of stabilization in some of our key end markets such as industrial and public utilities, as well as relative strength in Europe,” Loranger said. “We believe the improvement we saw in the back half of 2013 will carry into 2014, combining with our continued focus on cost control to enable potential upside for our full year earnings.”
Fourth Quarter Segment Results
Water Infrastructure
Xylem’s Water Infrastructure segment consists of its businesses serving clean water delivery, wastewater transport and treatment, dewatering and analytical instrumentation.
| • | Fourth quarter 2013 revenue was $691 million, up 8 percent compared with the fourth quarter 2012, reflecting improvement in Transport business in the Americas and Europe. |
| • | Fourth quarter adjusted segment operating income, which excludes $12 million of restructuring, realignment and other special items, was $112 million, up 7 percent over the same period in 2012. Adjusted operating margin for the quarter declined 30 basis points, including 150 basis points of unfavorable foreign exchange impacts, acquisitions and lower price. |
Applied Water
Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, industrial and agricultural applications.
| • | Fourth quarter 2013 revenue was $358 million, up 3 percent compared with the fourth quarter 2012, with growth coming in industrial and irrigation applications. |
| • | Fourth quarter adjusted segment operating income, which excludes $4 million of restructuring and realignment costs, was $46 million, 15 percent higher than the |
| comparable period last year. Adjusted operating margin grew 120 basis points primarily driven by the benefits of cost reduction actions taken throughout the year. |
Supplemental information on Xylem’s fourth quarter and full year 2013 earnings and reconciliations for certain non-GAAP items is posted at investors.xyleminc.com.
About Xylem
Xylem (XYL) is a leading global water technology provider, enabling customers to transport, treat, test and efficiently use water in public utility, residential and commercial building services, industrial and agricultural settings. The company does business in more than 150 countries through a number of market-leading product brands, and its people bring broad applications expertise with a strong focus on finding local solutions to the world’s most challenging water and wastewater problems. Xylem is headquartered in Rye Brook, N.Y., with 2013 revenues of $3.8 billion and more than 12,500 employees worldwide. Xylem was named to the Dow Jones Sustainability World Index for the last two years for advancing sustainable business practices and solutions worldwide.
The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all — that which occurs in nature. For more information, please visit us at www.xyleminc.com.
Forward-Looking Statements
This document contains information that may constitute “forward-looking statements.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.
These forward-looking statements include, but are not limited to, statements about the capitalization of Xylem Inc. (the “Company”), the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals, and any discussion of future operating or financial performance. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to orders, revenues, operating margins and earnings per share growth, and statements expressing general views about future operating results — are forward-looking statements.
Caution should be taken not to place undue reliance on any such forward-looking statements because they involve risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such statements. The Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the Company’s historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those set forth in Item 1A of our Annual Report on Form 10-K, and those described from time to time in subsequent reports filed with the Securities and Exchange Commission.
###
XYLEM INC. AND SUBSIDIARIES
CONSOLIDATED AND COMBINED INCOME STATEMENTS
(In Millions, except per share data)
| Year Ended December 31, |
2013 | 2012 | 2011 | |||||||||
| Revenue |
$ | 3,837 | $ | 3,791 | $ | 3,803 | ||||||
| Cost of revenue |
2,338 | 2,289 | 2,342 | |||||||||
|
|
|
|
|
|
|
|||||||
| Gross profit |
1,499 | 1,502 | 1,461 | |||||||||
| Selling, general and administrative expenses |
986 | 914 | 877 | |||||||||
| Research and development expenses |
104 | 106 | 100 | |||||||||
| Separation costs |
4 | 22 | 87 | |||||||||
| Restructuring and asset impairments charges |
42 | 17 | 2 | |||||||||
|
|
|
|
|
|
|
|||||||
| Operating income |
363 | 443 | 395 | |||||||||
| Interest expense |
55 | 55 | 17 | |||||||||
| Other non-operating (expense) income, net |
(10 | ) | — | 5 | ||||||||
|
|
|
|
|
|
|
|||||||
| Income before taxes |
298 | 388 | 383 | |||||||||
| Income tax expense |
70 | 91 | 104 | |||||||||
|
|
|
|
|
|
|
|||||||
| Net income |
$ | 228 | $ | 297 | $ | 279 | ||||||
|
|
|
|
|
|
|
|||||||
| Earnings per share: |
||||||||||||
| Basic |
$ | 1.23 | $ | 1.60 | $ | 1.51 | ||||||
| Diluted |
$ | 1.22 | $ | 1.59 | $ | 1.50 | ||||||
| Weighted average number of shares – Basic |
185.2 | 185.8 | 185.1 | |||||||||
| Weighted average number of shares – Diluted |
186.0 | 186.2 | 185.3 | |||||||||
XYLEM INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In Millions, except per share amounts)
| December 31, |
2013 | 2012 | ||||||
| ASSETS |
||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | 533 | $ | 504 | ||||
| Receivables, less allowances for discounts and doubtful accounts of $31 and $34 in 2013 and 2012, respectively |
817 | 776 | ||||||
| Inventories, net |
475 | 443 | ||||||
| Prepaid and other current assets |
143 | 110 | ||||||
| Deferred income tax assets |
41 | 41 | ||||||
|
|
|
|
|
|||||
| Total current assets |
2,009 | 1,874 | ||||||
| Property, plant and equipment, net |
488 | 487 | ||||||
| Goodwill |
1,718 | 1,647 | ||||||
| Other intangible assets, net |
488 | 484 | ||||||
| Other non-current assets |
191 | 187 | ||||||
|
|
|
|
|
|||||
| Total assets |
$ | 4,894 | $ | 4,679 | ||||
|
|
|
|
|
|||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | 332 | $ | 332 | ||||
| Accrued and other current liabilities |
477 | 443 | ||||||
| Short-term borrowings and current maturities of long-term debt |
42 | 6 | ||||||
|
|
|
|
|
|||||
| Total current liabilities |
851 | 781 | ||||||
| Long-term debt |
1,199 | 1,199 | ||||||
| Accrued postretirement benefits |
348 | 400 | ||||||
| Deferred income tax liabilities |
178 | 173 | ||||||
| Other non-current accrued liabilities |
79 | 52 | ||||||
|
|
|
|
|
|||||
| Total liabilities |
2,655 | 2,605 | ||||||
|
|
|
|
|
|||||
| Stockholders’ equity: |
||||||||
| Common Stock — par value $0.01 per share: |
||||||||
| Authorized 750.0 shares, issued 187.6 and 186.2 shares in 2013 and 2012, respectively |
2 | 2 | ||||||
| Capital in excess of par value |
1,753 | 1,706 | ||||||
| Retained earnings |
405 | 264 | ||||||
| Treasury stock – at cost 3.0 shares and 0.5 shares in 2013 and 2012, respectively |
(86 | ) | (13 | ) | ||||
| Accumulated other comprehensive income |
165 | 115 | ||||||
|
|
|
|
|
|||||
| Total stockholders’ equity |
2,239 | 2,074 | ||||||
|
|
|
|
|
|||||
| Total liabilities and stockholders’ equity |
$ | 4,894 | $ | 4,679 | ||||
|
|
|
|
|
|||||
XYLEM INC. AND SUBSIDIARIES
CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS
(In Millions)
| Year Ended December 31, |
2013 | 2012 | 2011 | |||||||||
| Operating Activities |
||||||||||||
| Net income |
$ | 228 | $ | 297 | $ | 279 | ||||||
| Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||||
| Depreciation |
99 | 94 | 93 | |||||||||
| Amortization |
51 | 48 | 44 | |||||||||
| Deferred income taxes |
(14 | ) | 1 | 8 | ||||||||
| Share-based compensation |
27 | 22 | 13 | |||||||||
| Non-cash separation costs |
— | — | 10 | |||||||||
| Restructuring and asset impairment charges, net |
42 | 17 | 2 | |||||||||
| Other, net |
15 | 2 | 5 | |||||||||
| Payments of restructuring |
(35 | ) | (9 | ) | (7 | ) | ||||||
| Contributions to postretirement benefit plans |
(43 | ) | (46 | ) | (16 | ) | ||||||
| Changes in assets and liabilities (net of acquisitions): |
||||||||||||
| Changes in receivables |
(47 | ) | 2 | (61 | ) | |||||||
| Changes in inventories |
(39 | ) | 5 | (18 | ) | |||||||
| Changes in accounts payable |
4 | (4 | ) | (9 | ) | |||||||
| Changes in accrued liabilities |
16 | (28 | ) | 53 | ||||||||
| Changes in accrued taxes |
20 | (17 | ) | 56 | ||||||||
| Net changes in other assets and liabilities |
— | 12 | (3 | ) | ||||||||
|
|
|
|
|
|
|
|||||||
| Net Cash — Operating activities |
324 | 396 | 449 | |||||||||
|
|
|
|
|
|
|
|||||||
| Investing Activities |
||||||||||||
| Capital expenditures |
(126 | ) | (112 | ) | (126 | ) | ||||||
| Proceeds from the sale of property, plant and equipment |
6 | 5 | 11 | |||||||||
| Acquisitions of businesses and assets, net of cash acquired |
(81 | ) | (41 | ) | (309 | ) | ||||||
| Other, net |
2 | 1 | 1 | |||||||||
|
|
|
|
|
|
|
|||||||
| Net Cash — Investing activities |
(199 | ) | (147 | ) | (423 | ) | ||||||
|
|
|
|
|
|
|
|||||||
| Financing Activities |
||||||||||||
| Net transfer (to)/from former parent |
— | (9 | ) | (995 | ) | |||||||
| Issuance of short-term debt |
39 | 13 | 5 | |||||||||
| Issuance of senior notes, net of discount |
— | — | 1,198 | |||||||||
| Principal payments of debt and capital lease obligations |
(2 | ) | (14 | ) | (8 | ) | ||||||
| Purchase of Xylem common stock |
(73 | ) | (13 | ) | — | |||||||
| Proceeds from exercise of employee stock options |
23 | 24 | 1 | |||||||||
| Payments of debt issuance costs |
— | — | (10 | ) | ||||||||
| Dividends paid |
(87 | ) | (75 | ) | (19 | ) | ||||||
|
|
|
|
|
|
|
|||||||
| Net Cash — Financing activities |
(100 | ) | (74 | ) | 172 | |||||||
|
|
|
|
|
|
|
|||||||
| Effect of exchange rate changes on cash |
4 | 11 | (11 | ) | ||||||||
|
|
|
|
|
|
|
|||||||
| Net change in cash and cash equivalents |
29 | 186 | 187 | |||||||||
| Cash and cash equivalents at beginning of year |
504 | 318 | 131 | |||||||||
|
|
|
|
|
|
|
|||||||
| Cash and cash equivalents at end of year |
$ | 533 | $ | 504 | $ | 318 | ||||||
|
|
|
|
|
|
|
|||||||
| Supplemental disclosure of cash flow information: |
||||||||||||
| Cash paid during the year for: |
||||||||||||
| Interest |
$ | 51 | $ | 53 | $ | — | ||||||
| Income taxes (net of refunds received) |
$ | 65 | $ | 104 | $ | 64 | ||||||
Xylem Inc. Non-GAAP Measures
Management views key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, free cash flow, working capital, and backlog, among others. In addition, we consider certain measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operations as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:
“Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of foreign currency fluctuations, intercompany transactions, and contributions from acquisitions and divestitures. Divestitures include sales of portions of our business that did not meet the criteria for classification as a discontinued operation or insignificant portions of our business that we did not classify as a discontinued operation. The period-over-period change resulting from foreign currency fluctuations assumes no change in exchange rates from the prior period.
“Constant currency” defined as financial results adjusted for currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
“EBITDA” defined as earnings before interest, taxes, depreciation, amortization expense, and share-based compensation. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude for non-recurring separation costs associated with the Xylem spin-off from ITT Corporation as well as non-recurring restructuring and realignment costs.
“Adjusted Operating Income”, “Adjusted Segment Operating Income”, and “Adjusted EPS” defined as operating income and earnings per share, adjusted to exclude non-recurring separation costs associated with the Xylem spin-off from ITT Corporation, non-recurring restructuring and realignment costs and tax-related special items.
“Normalized EPS” defined as adjusted earnings per share, as well as adjustments to reflect the incremental current period amount of interest expense and stand alone costs in the prior comparable period.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flows does not consider non-discretionary cash payments, such as debt.
“Realignment costs” defined as non-recurring costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, relocation, travel and other costs.
“Special charges “defined as costs incurred by the Company associated with the settlement of legal proceedings with Xylem Group LLC and certain costs incurred for the change in chief executive officer made during the third quarter of 2013, as well as costs incurred in the fourth quarter of 2013 for the contractual indemnification of federal tax obligations to ITT and costs associated with a legal judgment arising from a historical acquisition matter.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Order Growth
($ Millions)
| (As Reported - GAAP) | (As Adjusted - Organic) | Constant Currency | ||||||||||||||||||||||||||||||||||||||
| (A) | (B) | (C) | (D) | (E) | (F) = B+C+D+E | (G) = F/A | (H) = (F - C) / A | |||||||||||||||||||||||||||||||||
| Orders | Orders | Change 2013 v. 2012 |
% Change 2013 v. 2012 |
Acquisitions / Divestitures |
FX Contribution |
Eliminations | Change Adj. 2013 v. 2012 |
% Change Adj. 2013 v. 2012 |
||||||||||||||||||||||||||||||||
| 2013 | 2012 | |||||||||||||||||||||||||||||||||||||||
| Year Ended December 31 |
||||||||||||||||||||||||||||||||||||||||
| Xylem Inc. |
3,912 | 3,782 | 130 | 3 | % | (87 | ) | — | — | 43 | 1 | % | 3 | % | ||||||||||||||||||||||||||
| Water infrastructure |
2,510 | 2,421 | 89 | 4 | % | (87 | ) | 6 | (2 | ) | 6 | 0 | % | 4 | % | |||||||||||||||||||||||||
| Applied Water |
1,468 | 1,423 | 45 | 3 | % | — | (8 | ) | 1 | 38 | 3 | % | 3 | % | ||||||||||||||||||||||||||
| Quarter Ended December 31 |
||||||||||||||||||||||||||||||||||||||||
| Xylem Inc. |
986 | 926 | 60 | 6 | % | (16 | ) | (1 | ) | — | 43 | 5 | % | 6 | % | |||||||||||||||||||||||||
| Water infrastructure |
645 | 602 | 43 | 7 | % | (16 | ) | 2 | (2 | ) | 27 | 4 | % | 7 | % | |||||||||||||||||||||||||
| Applied Water |
357 | 337 | 20 | 6 | % | — | (4 | ) | — | 16 | 5 | % | 5 | % | ||||||||||||||||||||||||||
| Quarter Ended September 30 |
||||||||||||||||||||||||||||||||||||||||
| Xylem Inc. |
955 | 882 | 73 | 8 | % | (20 | ) | 1 | — | 54 | 6 | % | 8 | % | ||||||||||||||||||||||||||
| Water infrastructure |
617 | 564 | 53 | 9 | % | (20 | ) | 3 | — | 36 | 6 | % | 10 | % | ||||||||||||||||||||||||||
| Applied Water |
355 | 334 | 21 | 6 | % | — | (3 | ) | 1 | 19 | 6 | % | 6 | % | ||||||||||||||||||||||||||
| Quarter Ended June 30 |
||||||||||||||||||||||||||||||||||||||||
| Xylem Inc. |
1,009 | 970 | 39 | 4 | % | (25 | ) | (2 | ) | — | 12 | 1 | % | 4 | % | |||||||||||||||||||||||||
| Water infrastructure |
647 | 617 | 30 | 5 | % | (25 | ) | (1 | ) | — | 4 | 1 | % | 5 | % | |||||||||||||||||||||||||
| Applied Water |
378 | 370 | 8 | 2 | % | — | (1 | ) | 1 | 8 | 2 | % | 2 | % | ||||||||||||||||||||||||||
| Quarter Ended March 31 |
||||||||||||||||||||||||||||||||||||||||
| Xylem Inc. |
962 | 1,004 | (42 | ) | -4 | % | (26 | ) | 2 | — | (66 | ) | -7 | % | -4 | % | ||||||||||||||||||||||||
| Water infrastructure |
601 | 638 | (37 | ) | -6 | % | (26 | ) | 2 | — | (61 | ) | -10 | % | -5 | % | ||||||||||||||||||||||||
| Applied Water |
378 | 382 | (4 | ) | -1 | % | — | — | (1 | ) | (5 | ) | -1 | % | -1 | % | ||||||||||||||||||||||||
Note: Due to rounding the sum of segment amounts may not agree to Xylem totals.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue
($ Millions)
| (As Reported - GAAP) | (As Adjusted - Organic) | Constant Currency | ||||||||||||||||||||||||||||||||||||||
| (A) | (B) | (C) | (D) | (E) | (F) = B+C+D+E | (G) = F/A | (H) = (F - C) / A | |||||||||||||||||||||||||||||||||
| Revenue | Revenue | Change 2013 v. 2012 |
% Change 2013 v. 2012 |
Acquisitions / Divestitures |
FX Contribution |
Eliminations | Change Adj. 2013 v. 2012 |
% Change Adj. 2013 v. 2012 |
||||||||||||||||||||||||||||||||
| 2013 | 2012 | |||||||||||||||||||||||||||||||||||||||
| Year Ended December 31 |
||||||||||||||||||||||||||||||||||||||||
| Xylem Inc. |
3,837 | 3,791 | 46 | 1 | % | (82 | ) | (3 | ) | — | (39 | ) | -1 | % | 1 | % | ||||||||||||||||||||||||
| Water infrastructure |
2,457 | 2,425 | 32 | 1 | % | (82 | ) | 4 | — | (46 | ) | -2 | % | 1 | % | |||||||||||||||||||||||||
| Applied Water |
1,444 | 1,424 | 20 | 1 | % | — | (9 | ) | (6 | ) | 5 | 0 | % | 0 | % | |||||||||||||||||||||||||
| Quarter Ended December 31 |
||||||||||||||||||||||||||||||||||||||||
| Xylem Inc. |
1,033 | 969 | 64 | 7 | % | (15 | ) | (1 | ) | — | 48 | 5 | % | 7 | % | |||||||||||||||||||||||||
| Water Infrastructure |
691 | 637 | 54 | 8 | % | (15 | ) | 2 | (1 | ) | 40 | 6 | % | 9 | % | |||||||||||||||||||||||||
| Applied Water |
358 | 346 | 12 | 3 | % | — | (4 | ) | (2 | ) | 6 | 2 | % | 2 | % | |||||||||||||||||||||||||
| Quarter Ended September 30 |
||||||||||||||||||||||||||||||||||||||||
| Xylem Inc. |
965 | 931 | 34 | 4 | % | (21 | ) | — | — | 13 | 1 | % | 4 | % | ||||||||||||||||||||||||||
| Water infrastructure |
619 | 595 | 24 | 4 | % | (21 | ) | 3 | 1 | 7 | 1 | % | 5 | % | ||||||||||||||||||||||||||
| Applied Water |
360 | 350 | 10 | 3 | % | — | (4 | ) | — | 6 | 2 | % | 2 | % | ||||||||||||||||||||||||||
| Quarter Ended June 30 |
||||||||||||||||||||||||||||||||||||||||
| Xylem Inc. |
960 | 966 | (6 | ) | -1 | % | (23 | ) | (4 | ) | — | (33 | ) | -3 | % | -1 | % | |||||||||||||||||||||||
| Water infrastructure |
596 | 609 | (13 | ) | -2 | % | (23 | ) | (2 | ) | — | (38 | ) | -6 | % | -2 | % | |||||||||||||||||||||||
| Applied Water |
381 | 373 | 8 | 2 | % | — | (1 | ) | (2 | ) | 5 | 1 | % | 1 | % | |||||||||||||||||||||||||
| Quarter Ended March 31 |
||||||||||||||||||||||||||||||||||||||||
| Xylem Inc. |
879 | 925 | (46 | ) | -5 | % | (23 | ) | 2 | — | (67 | ) | -7 | % | -5 | % | ||||||||||||||||||||||||
| Water infrastructure |
551 | 584 | (33 | ) | -6 | % | (23 | ) | 1 | — | (55 | ) | -9 | % | -5 | % | ||||||||||||||||||||||||
| Applied Water |
345 | 355 | (10 | ) | -3 | % | — | — | (2 | ) | (12 | ) | -3 | % | -3 | % | ||||||||||||||||||||||||
Note: Due to rounding the sum of segment amounts may not agree to Xylem totals.
Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income
($ Millions)
| Q4 | YTD | |||||||||||||||
| ‘13 | ‘12 | ‘13 | ‘12 | |||||||||||||
| Total Revenue |
||||||||||||||||
| • Total Xylem |
1,033 | 969 | 3,837 | 3,791 | ||||||||||||
| • Water Infrastructure |
691 | 637 | 2,457 | 2,425 | ||||||||||||
| • Applied Water |
358 | 346 | 1,444 | 1,424 | ||||||||||||
| Operating Income |
||||||||||||||||
| • Total Xylem |
129 | 104 | 363 | 443 | ||||||||||||
| • Water Infrastructure |
100 | 89 | 271 | 342 | ||||||||||||
| • Applied Water |
42 | 35 | 167 | 170 | ||||||||||||
| Operating Margin |
||||||||||||||||
| • Total Xylem |
12.5 | % | 10.7 | % | 9.5 | % | 11.7 | % | ||||||||
| • Water Infrastructure |
14.5 | % | 14.0 | % | 11.0 | % | 14.1 | % | ||||||||
| • Applied Water |
11.7 | % | 10.1 | % | 11.6 | % | 11.9 | % | ||||||||
| Separation Costs |
||||||||||||||||
| • Total Xylem |
— | 7 | — | 22 | ||||||||||||
| • Water Infrastructure |
— | 1 | — | 4 | ||||||||||||
| • Applied Water |
— | — | — | 2 | ||||||||||||
| Special Charges |
||||||||||||||||
| • Total Xylem |
4 | — | 24 | — | ||||||||||||
| • Water Infrastructure |
4 | — | 4 | — | ||||||||||||
| • Applied Water |
— | — | — | — | ||||||||||||
| Restructuring & Realignment Costs |
||||||||||||||||
| • Total Xylem |
12 | 19 | 64 | 24 | ||||||||||||
| • Water Infrastructure |
8 | 15 | 48 | 19 | ||||||||||||
| • Applied Water |
4 | 5 | 16 | 5 | ||||||||||||
| Adjusted Operating Income* |
||||||||||||||||
| • Total Xylem |
145 | 130 | 451 | 489 | ||||||||||||
| • Water Infrastructure |
112 | 105 | 323 | 365 | ||||||||||||
| • Applied Water |
46 | 40 | 183 | 177 | ||||||||||||
| Adjusted Operating Margin* |
||||||||||||||||
| • Total Xylem |
14.0 | % | 13.4 | % | 11.8 | % | 12.9 | % | ||||||||
| • Water Infrastructure |
16.2 | % | 16.5 | % | 13.1 | % | 15.1 | % | ||||||||
| • Applied Water |
12.8 | % | 11.6 | % | 12.7 | % | 12.4 | % | ||||||||
| * | Adjusted Operating Income excludes restructuring & realignment costs and special charges in 2013 and excludes restructuring & realignment costs and non-recurring separation costs in 2012. |
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
| Q4 2012 | Q4 2013 | |||||||||||||||||||||||
| As Reported |
Adjustments | Adjusted | As Reported |
Adjustments | Adjusted | |||||||||||||||||||
| Total Revenue |
969 | 969 | 1,033 | 1,033 | ||||||||||||||||||||
| Operating Income |
104 | 26 | a | 130 | 129 | 16 | c | 145 | ||||||||||||||||
| Operating Margin |
10.7 | % | 13.4 | % | 12.5 | % | 14.0 | % | ||||||||||||||||
| Interest Expense |
(14 | ) | (14 | ) | (14 | ) | (14 | ) | ||||||||||||||||
| Other Non-Operating Income (Expense) |
(1 | ) | (1 | ) | (8 | ) | 8 | d | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Income before Taxes |
89 | 26 | 115 | 107 | 24 | 131 | ||||||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||
| Provision for Income Taxes |
(16 | ) | (11 | )b | (27 | ) | (39 | ) | 11e | (28 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net Income |
73 | 15 | 88 | 68 | 35 | 103 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Diluted Shares |
186.5 | 186.5 | 185.6 | 185.6 | ||||||||||||||||||||
| Diluted EPS |
$ | 0.39 | $ | 0.08 | $ | 0.47 | $ | 0.37 | $ | 0.19 | $ | 0.56 | ||||||||||||
| Q4 YTD 2012 | Q4 YTD 2013 | |||||||||||||||||||||||
| As Reported |
Adjustments | Adjusted | As Reported |
Adjustments | Adjusted | |||||||||||||||||||
| Total Revenue |
3,791 | 3,791 | 3,837 | 3,837 | ||||||||||||||||||||
| Operating Income |
443 | 46 | a | 489 | 363 | 88 | c | 451 | ||||||||||||||||
| Operating Margin |
11.7 | % | 12.9 | % | 9.5 | % | 11.8 | % | ||||||||||||||||
| Interest Expense |
(55 | ) | (55 | ) | (55 | ) | (55 | ) | ||||||||||||||||
| Other Non-Operating Income (Expense) |
— | — | (10 | ) | 8d | (2 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Income before Taxes |
388 | 46 | 434 | 298 | 96 | 394 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Provision for Income Taxes |
(91 | ) | (13 | )b | (104 | ) | (70 | ) | (13 | )e | (83 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net Income |
297 | 33 | 330 | 228 | 83 | 311 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Diluted Shares |
186.2 | 186.2 | 186.0 | 186.0 | ||||||||||||||||||||
| Diluted EPS |
$ | 1.59 | $ | 0.18 | $ | 1.77 | $ | 1.22 | $ | 0.45 | $ | 1.67 | ||||||||||||
| a | One time separation costs and restructuring & realignment costs |
| b | Net tax impact of separation costs, restructuring & realignment costs and special tax items |
| c | Restructuring & realignment costs and special charges |
| d | Special charges |
| e | Net tax impact of restructuring & realignment costs, special charges and special tax items |
Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow
($ Millions)
| Year Ended | ||||||||
| 2013 | 2012 | |||||||
| Net Cash - Operating Activities |
$ | 324 | $ | 396 | ||||
| Capital Expenditures |
(126 | ) | (112 | ) | ||||
|
|
|
|
|
|||||
| Free Cash Flow, including separation costs |
198 | 284 | ||||||
| Cash Paid for Separation Costs (incl. Capex) |
— | 28 | ||||||
|
|
|
|
|
|||||
| Free Cash Flow, excluding separation costs* |
$ | 198 | $ | 312 | ||||
|
|
|
|
|
|||||
| Net Income |
228 | 297 | ||||||
| Separation Costs, net of tax (incl. tax friction) |
— | 16 | ||||||
|
|
|
|
|
|||||
| Net Income, excluding separation costs* |
$ | 228 | $ | 313 | ||||
|
|
|
|
|
|||||
| Free Cash Flow Conversion |
87 | % | 100 | % | ||||
|
|
|
|
|
|||||
| * | Separation costs are not excluded in 2013 |